Realgar-Indigo Naturalis Formula
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Realgar-Indigo Naturalis Formula, covering 2021-09-08 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). [Phase 3]